4,644 Shares in CVS Health Corporation (NYSE:CVS) Bought by Beverly Hills Private Wealth LLC

Beverly Hills Private Wealth LLC purchased a new stake in CVS Health Corporation (NYSE:CVS - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 4,644 shares of the pharmacy operator's stock, valued at approximately $315,000.

Other hedge funds have also recently bought and sold shares of the company. Whitebox Advisors LLC bought a new position in CVS Health in the fourth quarter valued at approximately $249,000. Fairfax Financial Holdings Ltd. Can bought a new position in CVS Health in the fourth quarter valued at approximately $121,742,000. Bank of New York Mellon Corp grew its stake in CVS Health by 2.1% in the first quarter. Bank of New York Mellon Corp now owns 8,981,262 shares of the pharmacy operator's stock valued at $608,481,000 after purchasing an additional 183,813 shares in the last quarter. Lazard Asset Management LLC grew its stake in CVS Health by 7.3% in the fourth quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator's stock valued at $192,617,000 after purchasing an additional 293,406 shares in the last quarter. Finally, Teacher Retirement System of Texas grew its stake in CVS Health by 248.0% in the first quarter. Teacher Retirement System of Texas now owns 282,232 shares of the pharmacy operator's stock valued at $19,121,000 after purchasing an additional 201,120 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

NYSE CVS traded down $0.89 during midday trading on Friday, hitting $64.73. The company had a trading volume of 7,020,831 shares, compared to its average volume of 10,796,063. The company has a market capitalization of $81.88 billion, a PE ratio of 15.45, a P/E/G ratio of 0.94 and a beta of 0.57. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The firm has a 50-day moving average price of $65.05 and a 200-day moving average price of $62.22. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company's quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 EPS. As a group, analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.11%. CVS Health's dividend payout ratio (DPR) is currently 63.48%.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the transaction, the director directly owned 12,007 shares in the company, valued at $764,845.90. This represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 1.22% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have recently commented on CVS. Jefferies Financial Group lifted their target price on CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Barclays set a $79.00 target price on CVS Health and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Robert W. Baird lifted their target price on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Finally, Wells Fargo & Company reiterated an "overweight" rating and set a $84.00 target price (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, CVS Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $75.06.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.